Hostname: page-component-7f64f4797f-m2b9p Total loading time: 0 Render date: 2025-11-03T05:11:27.119Z Has data issue: false hasContentIssue false
  • English
  • Français

Double-Blind Study of Imipramine versus Phenelzine in Melancholias and Dysthymic Disorders

Published online by Cambridge University Press:  02 January 2018

J. Vallejo ,
C. Gasto ,
R. Catalan  and
M. Salamero
J. Vallejo*
Affiliation:
Department of Psychiatry, University Hospital, University of Barcelona
C. Gasto
Affiliation:
Department of Psychiatry, University Hospital, University of Barcelona
R. Catalan
Affiliation:
Department of Psychiatry, University Hospital, University of Barcelona
M. Salamero
Affiliation:
Department of Psychiatry, University Hospital, University of Barcelona
*
∗ Department of Psychiatry, University Hospital, University of Barcelona
Get access Rights & Permissions [Opens in a new window]

Abstract

In a 6-week double-blind trial, the efficacy of imipramine and high dose phenelzine were compared in the treatment of Major Depression with Melancholia, and Dysthymic Disorder (DSM-III). Both drugs were found to be equally efficacious in the treatment of 32 patients suffering from Major Depression. In 32 Dysthymic patients, phenelzine in high doses was found to be superior to imipramine. The clinical implications of these findings are discussed.

Information

Type
Papers
Information
The British Journal of Psychiatry , Volume 151 , Issue 5 , November 1987 , pp. 639 - 642
Copyright
Copyright © 1987 The Royal College of Psychiatrists 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Article purchase

Temporarily unavailable

References

Carroll, B., Feinberg, M., Greden, J., Tarika, J., Albala, A., Haskett, R., James, N., Kronfol, Z., Lohr, N., Steiner, M., de Vigne, J. & Young, E. (1981) A specific laboratory test for the diagnosis of melancholia: standardization, validation and clinical utility. Archives of General Psychiatry, 38, 15–22.Google Scholar
Hamilton, M. (1982) The effect of treatment on the melancholias (depressions). British Journal of Psychiatry, 14, 223–230.CrossRefGoogle Scholar
Klein, D. & Davis, J. (1969) Diagnosis and Drug Treatment of Psychiatric Disorders, Baltimore: Williams & Wilkins.Google Scholar
Liebowitz, M., Quitkin, F., Stewart, J., McGrath, P., Harrison, W., Rabkin, J., Tricamo, E., Markowitz, J. & Klein, D. (1984) Phenelzine vs. imipramine in atypical depression. Archives of General Psychiatry, 41, 669–677.Google Scholar
Medical Research Council (1965) Clinical trial of the treatment of depressive illness. British Medical Journal, i, 881–886.Google Scholar
Morris, J. & Beck, A. (1974) The efficacy of antidepressant drugs. Archives of General Psychiatry, 30, 667–674.CrossRefGoogle ScholarPubMed
Nies, S. & Robinson, B. (1981) Comparison of clinical effects of amitriptyline and phelenzine treatment. In Monoamine Oxidase Inhibitors: the State of the Art (eds Youdim, M. & Paykel, E.). Chichester: John Wiley & Sons.Google Scholar
Paykel, E., Rowan, P., Parker, R. & Bmat, A. (1982) Response to phenelzine amitriptyline in subtypes of out-patient depression. Archives of General Psychiatry, 39, 1041–1049.Google Scholar
Rees, L. & Davies, B. (1961) Controlled trial of phenelzine (Nardil) in treatment of severe depressive illness. Journal of Mental Sciences, 107, 560–566.Google Scholar
Robinson, D., Nies, A., Ravaris, L. & Lamborn, K. (1973) The monoamine oxidase inhibitor, phenelzine, in the treatment of depressive-anxiety states. Archives of General Psychiatry, 29, 407–413.CrossRefGoogle ScholarPubMed
Rowan, P., Paykel, E., Parker, R. (1982) Phenelzine and amitriptyline: effects on symptoms of neurotic depression. British Journal of Psychiatry, 140, 475–483.Google Scholar
West, E. & Dally, P. (1959) Effects of iproniazid in depressive syndromes. British Medical Journal, i, 1491–1494.Google Scholar
Young, J., Lader, M. & Hughes, W. (1979) Controlled trial of trimipramine, monoamine oxidase inhibitors and combined treatment in depressed out-patients. British Medical Journal, ii, 1315–1317.CrossRefGoogle Scholar
Submit a response

eLetters

No eLetters have been published for this article.